keyword
https://read.qxmd.com/read/38619889/revolutionizing-transdermal-drug-delivery-unveiling-the-potential-of-cubosomes-and-ethosomes
#1
REVIEW
Preetha Balakrishnan, Sreerag Gopi
The area of drug delivery systems has witnessed significant advancements in recent years, with a particular focus on improving efficacy, stability, and patient compliance. Transdermal drug delivery offers numerous benefits compared to conventional methods of drug administration through the skin. It helps in avoiding gastric irritation, hepatic first-pass metabolism, and gastric degradation of the drug. It bypasses the gastrointestinal tract, eliminating the risk of first-pass metabolism and allowing drugs to be administered without being affected by pH, enzymes, or intestinal bacteria...
April 15, 2024: Journal of Materials Chemistry. B, Materials for Biology and Medicine
https://read.qxmd.com/read/38610820/antiviral-therapy-of-chronic-hepatitis-b-virus-between-present-and-future
#2
REVIEW
Mariana Daniela Ignat, Alexia Anastasia Stefania Balta, Raisa Eloise Barbu, Miruna Luminita Draganescu, Luiza Nechita, Doina Carina Voinescu, Aurel Nechita, Ioana Anca Stefanopol, Camelia Busila, Liliana Baroiu
Background/Objectives : The objective of this study was to analyze the results of clinical trials regarding long-term antiviral therapies in chronic hepatitis with HBV to compare current therapeutic protocols and to analyze the results of preliminary studies with new antiviral therapies for HBV. Methods : Clinical studies and meta-analyses from PubMed, Google Scholar, and Research Gate from 2011 to 2024 were analyzed on patients undergoing chronic antiviral therapy for HBV, and a retrospective observational study performed in our clinic on a group of 76 patients undergoing chronic therapy with entecavir was presented...
April 2, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38588691/hepatocellular-carcinoma-surveillance-among-people-living-with-hepatitis-b-in-senegal-sen-b-insights-from-a-prospective-cohort-study
#3
JOURNAL ARTICLE
Adrià Ramírez Mena, Mbaye Thiam, Daye Ka, Ibrahima Niang, Judicaël Tine, Louise Fortes, Kiné Ndiaye, Ousseynou Ndiaye, Maguette Fall, Assietou Gaye, Ndeye Fatou Ngom, Fatou Fall, Annalisa Berzigotti, Gregory Dale Kirk, Antoine Jaquet, Moussa Seydi, Gilles Wandeler
BACKGROUND: Chronic hepatitis B virus (HBV) infection is the predominant cause of hepatocellular carcinoma in west Africa, yet data on the incidence of HBV-related hepatocellular carcinoma remain scarce. We aimed to describe the uptake and early outcomes of systematic ultrasound-based hepatocellular carcinoma screening in SEN-B, which is a prospective HBV cohort in Senegal. METHODS: In this prospective cohort study, we included treatment-naive, HBsAg-positive individuals who were referred to the two infectious diseases clinics (the Department of Tropical and Infectious Diseases and Ambulatory Treatment Center) at Fann University Hospital of Dakar, Senegal, between Oct 1, 2019, and Oct 31, 2022...
April 5, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38584795/biological-depiction-of-lipodystrophy-and-its-associated-challenges-among-hiv-aids-patients-literature-review
#4
REVIEW
Tolera Ambisa Lamesa
Lipodystrophy syndrome is a medical condition characterized by the absence of adipose tissue without any underlying starvation or macromolecule breakdown. In HIV AIDS patients, the use of highly active antiretroviral therapy (HAART) can lead to an acquired form of lipodystrophy, with a prevalence ranging from 10% to 83% among HIV AIDS patients. It was aimed to review the current understanding of biological depiction and challenges related to lipodystrophy in AIDS patients. Relevant articles published in the English language were searched in PubMed, Google Scholar, and Google...
2024: HIV/AIDS: Research and Palliative Care
https://read.qxmd.com/read/38577537/advances-in-discovery-of-novel-investigational-agents-for-functional-cure-of-chronic-hepatitis-b-a-comprehensive-review-of-phases-ii-and-iii-therapeutic-agents
#5
REVIEW
Robert Lam, Joseph K Lim
Chronic hepatitis B virus (HBV) infection affects over 295 million people globally and an estimated 1.6 million people in the United States. It is associated with significant morbidity and mortality due to cirrhosis, liver failure, and liver cancer. Antiviral therapy with oral nucleos(t)ide analogues is associated with high rates of virologic suppression, which in turn has been associated with a decreased risk of liver complications. However, current antiviral regimens are limited by concerns with adverse effects, adherence, resistance, long-term treatment, and ongoing risk for liver events...
March 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38510983/long-term-open-label-vebicorvir-for-chronic-hbv-infection-safety-and-off-treatment-responses
#6
JOURNAL ARTICLE
Man-Fung Yuen, Scott Fung, Xiaoli Ma, Tuan T Nguyen, Tarek Hassanein, Hie-Won Hann, Magdy Elkhashab, Ronald G Nahass, James S Park, Ira M Jacobson, Walid S Ayoub, Steven-Huy Han, Edward J Gane, Katie Zomorodi, Ran Yan, Julie Ma, Steven J Knox, Luisa M Stamm, Maurizio Bonacini, Frank Weilert, Alnoor Ramji, Michael Bennett, Natarajan Ravendhran, Sing Chan, Douglas T Dieterich, Paul Yien Kwo, Eugene R Schiff, Ho S Bae, Jacob Lalezari, Kosh Agarwal, Mark S Sulkowski
BACKGROUND & AIMS: The investigational first-generation core inhibitor vebicorvir (VBR) demonstrated safety and antiviral activity over 24 weeks in two phase IIa studies in patients with chronic HBV infection. In this long-term extension study, patients received open-label VBR with nucleos(t)ide reverse transcriptase inhibitors (NrtIs). METHODS: Patients in this study (NCT03780543) previously received VBR + NrtI or placebo + NrtI in parent studies 201 (NCT03576066) or 202 (NCT03577171)...
April 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38487951/addressing-hepatitis-delta-in-primary-care-practices-in-the-us-a-narrative-review
#7
REVIEW
Tatyana Kushner, Richard R Andrews
OBJECTIVE: Infection with the hepatitis delta virus (HDV), a unique RNA virus that requires hepatitis B virus (HBV) antigens for its assembly, replication, and transmission, causes severe viral hepatitis. Compared to HBV monoinfection, HDV infection increases the risk of severe liver disease, necessity for liver transplant, and mortality. Global HDV prevalence estimates vary from 5% to 15% among persons with HBV, but screening guidelines for HDV are inconsistent; some recommend risk-based screening, while others recommend universal screening for all people with HBV...
March 15, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/38481490/providing-hemodialysis-in-unstable-areas-an-assessment-and-framework-for-effective-care
#8
JOURNAL ARTICLE
Sami Alasfar, Hani Alashavi, Khaled Hajj Nasan, Abd Aljabbar Haj Mousa, Camila Polinori, Valerie Luyckx, Mohamed Sekkarie, Saleh Kaysi, Lina Murad, Gilbert M Burnham
INTRODUCTION: Providing hemodialysis to patients with kidney failure (KF) in conflict-affected areas poses a significant challenge. Achieving and sustaining reasonable quality hemodialysis operations in such regions necessitates a comprehensive approach. METHODS: In the conflict area of Northwest (NW) Syria, a 3-phase project was initiated to address the quality of hemodialysis operations. The assessment phase involved the examination of infection prevention and control (IPC) protocols, staff training, medical protocols, individualized hemodialysis prescriptions, and laboratory testing capabilities...
March 2024: KI Reports
https://read.qxmd.com/read/38444112/what-does-the-scale-up-of-long-acting-hiv-pre-exposure-prophylaxis-mean-for-the-global-hepatitis-b-epidemic
#9
JOURNAL ARTICLE
Amir M Mohareb, Menan Gérard Kouamé, Marcellin Nouaman, Arthur Y Kim, Joseph Larmarange, Anne M Neilan, Karine Lacombe, Kenneth A Freedberg, Anders Boyd, Patrick Coffie, Emily P Hyle
INTRODUCTION: The HIV and hepatitis B virus (HBV) epidemics are interconnected with shared routes of transmission and specific antiviral drugs that are effective against both viruses. Nearly, 300 million people around the world live with chronic HBV, many of whom are from priority populations who could benefit from HIV prevention services. Oral pre-exposure prophylaxis (PrEP) for HIV has implications in the prevention and treatment of HBV infection, but many people at increased risk of HIV acquisition may instead prefer long-acting formulations of PrEP, which are currently not active against HBV...
March 2024: Journal of the International AIDS Society
https://read.qxmd.com/read/38433561/leveraging-opportunities-for-treatment-user-simplicity-lotus-navigating-the-current-treatment-landscape-for-achieving-hepatitis-c-virus-elimination-among-persons-who-inject-drugs
#10
REVIEW
Mark S Sulkowski, Anthony Martinez, Gia L Tyson, Kathleen Scholz, Ricardo A Franco, Anita Kohli, Susan F Julius, Paulina Deming, Scott A Fink, Keisa Lynch, Marina Roytman, Tuesdae R Stainbrook, Marshe D Turner, Matthew Viera-Briggs, Christian B Ramers
All-oral, direct-acting antivirals can cure hepatitis C virus (HCV) in almost all infected individuals; yet, many individuals with chronic HCV are not treated, and the incidence of acute HCV is increasing in some countries, including the United States. Strains on healthcare resources during the COVID-19 pandemic negatively impacted the progress toward the World Health Organization goal to eliminate HCV by 2030, especially among persons who inject drugs (PWID). Here, we present a holistic conceptual framework termed LOTUS (Leveraging Opportunities for Treatment/User Simplicity), designed to integrate the current HCV practice landscape and invigorate HCV treatment programs in the setting of endemic COVID-19: (A) treatment as prevention (especially among PWID), (B) recognition that HCV cure may be achieved with variable adherence with evidence supporting some forgiveness for missed doses, (C) treatment of all persons with active HCV infection (viremic), regardless of acuity, (D) minimal monitoring (MinMon) during treatment, and (E) rapid test and treat (TnT)...
March 3, 2024: Journal of Viral Hepatitis
https://read.qxmd.com/read/38385850/real-world-hepatitis-c-prevalence-and-treatment-uptake-at-opioid-agonist-therapy-clinics-in-ontario-canada
#11
JOURNAL ARTICLE
B Wolfson-Stofko, G Hirode, A Vanderhoff, J Karkada, C Capraru, M J Biondi, B Hansen, H Shah, H L A Janssen, J J Feld
Widespread screening for hepatitis C virus (HCV) is necessary for Canada to meet its HCV elimination goals by 2030. People who currently or previously injected drugs are at high risk for HCV. Opioid agonist therapy (OAT, such as methadone and buprenorphine) has been shown to help stabilize the lives of people who are opioid-dependent. The distribution of OAT in North America typically requires daily, weekly, or monthly clinic visits and presents an opportunity for engagement, screening and treatment for those at high-risk of HCV...
May 2024: Journal of Viral Hepatitis
https://read.qxmd.com/read/38344579/prolonged-atypical-and-fulminant-mpox-in-a-hiv-hbv-coinfected-patient-a-case-report
#12
Felipe de Jesus Perez-Hernandez, Victor Aaron Alvarez-Sanchez, Darwin Torres-Erazo, Monica Ceballos-Perez, Carlos David Franco-Gonzalez
Mpox (monkeypox) is a zoonotic disease that has been endemic in African countries for decades, with a recent global outbreak in countries around the world. A 39-year-old male with human immunodeficiency virus (HIV)-hepatitis B virus (HBV) coinfection and poor adherence to antiretroviral treatment, who was severely immunocompromised and had a concurrent diagnosis of Mpox, presented to our hospital with disseminated skin lesions (over 350 lesions), perianal ulcers, odynophagia, oral intolerance, diarrhea, and soft-tissue bacterial superinfection of the lower extremities...
January 2024: Curēus
https://read.qxmd.com/read/38265946/hiv-hepatitis-b-c-in-people-who-inject-drugs-in-india-a-systematic-review-of-regional-heterogeneity-overview-of-opioid-substitution-treatment
#13
JOURNAL ARTICLE
Lekhansh Shukla, Prakrithi Shivaprakash, M Suresh Kumar
BACKGROUND OBJECTIVES: This systematic review evaluates the human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV) burden among people who inject drugs (PWIDs) in India. In addition, we selectively examined research on opioid substitution treatment (OST)-related services due to their role in antiviral treatment uptake and adherence. METHODS: Data were sourced from peer-reviewed and government publications between 1991 and September 20, 2023, searched in MEDLINE, Scopus and EBSCOhost...
November 1, 2023: Indian Journal of Medical Research
https://read.qxmd.com/read/38262629/prediction-models-for-adverse-drug-reactions-during-tuberculosis-treatment-in-brazil
#14
JOURNAL ARTICLE
Felipe Ridolfi, Gustavo Amorim, Lauren S Peetluk, David W Haas, Cody Staats, Mariana Araújo-Pereira, Marcelo Cordeiro-Santos, Afrânio L Kritski, Marina C Figueiredo, Bruno B Andrade, Valeria C Rolla, Timothy R Sterling
BACKGROUND: Tuberculosis (TB) treatment-related adverse drug reactions (TB-ADR) can negatively affect adherence and treatment success rates. METHODS: We developed prediction models for TB-ADR, considering drug-susceptible pulmonary TB participants who initiated standard TB therapy. TB-ADR were determined by the physician attending the participant, assessing causality to TB drugs, the affected organ system, and grade. Potential baseline predictors of TB-ADR included concomitant medication (CM)-use, HIV-status, glycated hemoglobin (HbA1c), age, body mass index (BMI), sex, substance use, and TB drug metabolism variables (NAT2 acetylator profiles)...
January 23, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38161505/antiviral-therapy-favors-a-lower-risk-of-liver-cirrhosis-in-hbeag-negative-chronic-hepatitis-b-with-normal-alanine-transaminase-and-hbv-dna-positivity
#15
JOURNAL ARTICLE
Jing Zhou, Fa-Da Wang, Lan-Qing Li, Yu-Jin Li, Shi-Yan Wang, En-Qiang Chen
BACKGROUND AND AIMS: Direct evidence on the outcomes of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients with normal alanine transaminase after long-term antiviral treatment is lacking. METHODS: HBeAg-negative patients with normal ALT and positive HBV DNA (≥20 IU/mL) were retrospectively enrolled. The endpoints included virological response (HBV DNA<100 IU/mL), changes in aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 index (FIB-4), and the incidence of liver nodules, cirrhosis, and hepatocellular carcinoma (HCC)...
December 28, 2023: Journal of Clinical and Translational Hepatology
https://read.qxmd.com/read/38107097/a-narrative-review-on-the-role-of-hesperidin-on-metabolic-parameters-liver-enzymes-and-inflammatory-markers-in-nonalcoholic-fatty-liver-disease
#16
REVIEW
Nava Morshedzadeh, Amirhossein Ramezani Ahmadi, Vahideh Behrouz, Elias Mir
Insulin resistance, oxidative stress, hyperlipidemia, and inflammation play main roles in the development of nonalcoholic fatty liver disease (NAFLD). Some studies have reported that hesperidin can reduce hyperglycemia and hyperlipidemia by inhibiting inflammatory pathways. In the current study, our purpose was to evaluate whether it can influence the primary parameters in NAFLD and improve the treatment effectiveness for future trials. Various studies have found that hesperidin involves multiple signaling pathways such as cell proliferation, lipid and glucose metabolism, insulin resistance, oxidative stress, and inflammation, which can potentially affect NAFLD development and prognosis...
December 2023: Food Science & Nutrition
https://read.qxmd.com/read/38096116/first-15-years-of-assisted-reproductive-technology-using-washed-sperm-in-hiv-positive-individuals-under-antiretroviral-therapy-sweden-s-nationwide-outcomes
#17
JOURNAL ARTICLE
Fotios Sergouniotis, Jan I Olofsson, Katarina Westling, Kenny A Rodriguez-Wallberg
Antiretroviral therapy has made HIV a chronic infectious disease. In Sweden, assisted reproductive technologies using sperm washing were implemented in 2004 for treatment of all HIV-positive males in serodiscordant couples at Karolinska Hospital in Stockholm. This study aimed to assess efficacy and safety of this approach and to investigate the effect of antiretroviral regimens on sperm quality of men treated for HIV. The study included all HIV-positive men ( n  = 53) adherent to antiretroviral treatment, including nucleoside/nucleotide analog reverse-transcriptase inhibitors (NRTIs) combined with non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in 22 cases, or with other medication in 31 cases wishing fertility treatment...
December 2023: AIDS Patient Care and STDs
https://read.qxmd.com/read/38053533/patient-preferences-and-their-influence-on-chronic-hepatitis-b-a-review
#18
REVIEW
Lin Zhang, Yunyue Liu, Jinping Tian
Chronic hepatitis B (CHB) is a common chronic viral infectious disease that requires long-term treatment to control the condition and prevent complications. To standardize treatment regimens for CHB, professional associations have established relevant guidelines, but they have often overlooked patient preferences. Historically, in the treatment process, medical decisions were predominantly made by physicians or health care administrators, with limited patient involvement, leading to the neglect of patient preferences...
2023: Patient Preference and Adherence
https://read.qxmd.com/read/38049823/models-of-good-practice-to-enhance-infectious-disease-care-cascades-among-people-who-inject-drugs-a-qualitative-study-of-interventions-implemented-in-european-settings
#19
JOURNAL ARTICLE
Ilonka Horváth, Otilia Mårdh, Tanja Schwarz
BACKGROUND: People who inject drugs (PWID) in Europe are at an increased risk of HIV/AIDS, chronic viral hepatitis B (HBV) and C (HCV), and tuberculosis (TB). We aimed to complement the evidence base on interventions optimising their care cascade with evidence from models of good practice (MoGPs) implemented in the EU/EEA and countries from the Eastern European region. METHODS: A model of good practice (MoGP) was defined as (a package of) interventions with proven effectiveness in certain settings that are likely to be replicable and sustainable in other settings or countries...
December 4, 2023: BMC Health Services Research
https://read.qxmd.com/read/38043508/status-of-hiv-and-comorbidities-in-refugees-with-hiv-from-ukraine
#20
JOURNAL ARTICLE
Gerrit Ahrenstorf, Alexandra Dopfer-Jablonka, Oana Joean, Christine Knuth, Marc Silchmueller, Thea Thiele, Felix C Ringshausen, Hortense Slevogt, Torsten Witte, Georg M N Behrens
PURPOSE: To describe the clinical characteristics of refugees with HIV from Ukraine that seek continuation of medical care in Germany. METHODS: Fourty-six refugees with HIV that had left Ukraine between 24 February and 30 December 2022 were examined. Information on patients' history was obtained using a standardized questionnaire for clinical care. Interviews were conducted in Russian during their first clinical presentation. RESULTS: Fourty-six persons (41 females and 5 males) were included and their mean age was 39...
December 3, 2023: HIV Medicine
keyword
keyword
93537
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.